Recurrent non-muscle invasive bladder urothelial carcinoma
Clinical trials for Recurrent non-muscle invasive bladder urothelial carcinoma explained in plain language.
Never miss a new study
Get alerted when new Recurrent non-muscle invasive bladder urothelial carcinoma trials appear
Sign up with your email to follow new studies for Recurrent non-muscle invasive bladder urothelial carcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immunotherapy vs chemo: new hope for bladder cancer patients?
Disease control Recruiting nowThis phase II trial compares two treatments for high-grade T1 bladder cancer that hasn't spread. One group gets the immunotherapy drug pembrolizumab plus radiation, while the other gets standard chemotherapy (cisplatin, gemcitabine, 5-fluorouracil, or mitomycin-C) plus radiation.…
Matched conditions: RECURRENT NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Could a prostate drug help fight bladder cancer?
Knowledge-focused Recruiting nowThis early-stage trial is testing whether bicalutamide, a drug typically used for prostate cancer, can change a protein linked to bladder cancer growth. Researchers will compare men with non-muscle invasive bladder cancer who take the drug to those who don't. The goal is to see i…
Matched conditions: RECURRENT NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA
Phase 1 • Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Jul 09, 2026 00:00 UTC